Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 8/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.37 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.37 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9148985 | 0.96 | DNM1 (0.36) | DNM1MEN1KMT2AALDH1A1TSHR | |
| SCHEMBL5982480 | 0.94 | DNM1 (0.34) | DNM1MEN1KMT2AALDH1A1TSHR | |
| SCHEMBL2552172 | 0.92 | DNM1 (0.46) | DNM1MEN1KMT2AALDH1A1TSHR | |
| SCHEMBL2555453 | 0.92 | DNM1 (0.46) | DNM1MEN1KMT2AALDH1A1TSHR | |
| SCHEMBL21065564 | 0.91 | DNM1 (0.32) | DNM1MEN1KMT2AALDH1A1TSHR | |
| SCHEMBL21061273 | 0.90 | DNM1 (0.34) | DNM1MEN1KMT2AALDH1A1TSHR | |
| SCHEMBL1069120 | 0.89 | DNM1 (0.35) | DNM1MEN1KMT2AALDH1A1TSHR | |
| SCHEMBL706695 | 0.86 | ADRB2 (0.38) | ALDH1A1TSHRADRB2ADRB1ADRB3 | |
| SCHEMBL28805966 | 0.86 | ADRB2 (0.38) | ALDH1A1TSHRADRB2ADRB1ADRB3 | |
| SCHEMBL705364 | 0.86 | ADRB2 (0.38) | ALDH1A1TSHRADRB2ADRB1ADRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 224 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2771379-A2 | POLYMER, COMPOSITIONS AND PROCESS FOR PREPARING THEM | DSM IP Assets B.V. (NL) | 2014-09-03 | — | — | EP | claimed |
| US-20140242399-A1 | POLYMER, COMPOSITIONS AND PROCESS FOR PREPARING THEM | DSM IP ASSETS B.V. (NL) | 2014-08-28 | — | — | US | claimed |
| CN-103917568-A | Polymer, compositions and process for preparing them | DSM IP ASSETS BV | 2014-07-09 | — | — | CN | claimed |
| WO-2013060767-A2 | POLYMER, COMPOSITIONS AND PROCESS FOR PREPARING THEM | DSM IP ASSETS B.V. (NL) | 2013-05-02 | — | — | WO | claimed |
| US-6040101-A | Carrier particles for use in electrostatic image development and electrostatic image developer | NIPPON SHOKUBAI CO., LTD. (JP) | 2000-03-21 | — | — | US | claimed |
| EP-0330456-B1 | Preparation of silicon-containing polyimide precursor and cured polyimides obtained therefrom | CHISSO CORP (JP) | 1994-09-07 | — | — | EP | claimed |
| EP-0216007-B1 | PROCESS FOR PRODUCING ORGANIC SILICON-TERMINATED POLYIMIDE PRECURSOR AND POLYIMIDE | HITACHI, LTD. (JP) | 1991-03-13 | — | — | EP | claimed |
| US-4748228-A | Process for producing organic silicon-terminated polyimide precursor and polyimide | HITACHI. LTD. (JP) | 1988-05-31 | — | — | US | claimed |
| EP-0216007-A2 | Process for producing organic silicon-terminated polyimide precursor and polyimide | HITACHI, LTD. (JP) | 1987-04-01 | — | — | EP | claimed |
| US-12594700-B2 | Coatings from polyisocyanurate coatings (rim) and their use in injection molding processes | COVESTRO DEUTSCHLAND AG (DE) | 2026-04-07 | — | — | US | disclosed |
| US-12570899-B2 | Bright silver based quaternary nanostructures | SHOEI CHEMICAL INC. (JP) | 2026-03-10 | — | — | US | disclosed |
| EP-4606829-A1 | PROCESS FOR THE PREPARATION OF ALKOXYSILANE-FUNCTIONAL POLYURETHANES AND POLYURETHANE UREAS | Covestro Deutschland AG (DE) | 2025-08-27 | — | — | EP | disclosed |
| US-12331214-B2 | Resistant 2K-PUR coatings | COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) | 2025-06-17 | — | — | US | disclosed |
| US-12318752-B2 | Composite material and a method of preparing the same | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2025-06-03 | — | — | US | disclosed |
| EP-0330456-A1 | Preparation of silicon-containing polyimide precursor and cured polyimides obtained therefrom | CHISSO CORPORATION (JP) | 1989-08-30 | — | — | EP | disclosed |
| US-4748228-A | Process for producing organic silicon-terminated polyimide precursor and polyimide | HITACHI. LTD. (JP) | 1988-05-31 | — | — | US | disclosed |
| US-4686147-A | SILICONE CONTAINING POLYIMIDES INSULATION LAYER | HITACHI, LTD. (JP) | 1987-08-11 | — | — | US | disclosed |
| EP-0216007-A2 | Process for producing organic silicon-terminated polyimide precursor and polyimide | HITACHI, LTD. (JP) | 1987-04-01 | — | — | EP | disclosed |
| US-3950308-A | POLYAMIDES, POLYIMIDES, POLYAMIDE-IMIDES | CIBA-GEIGY CORPORATION (US) | 1976-04-13 | — | — | US | disclosed |
| US-3948835-A | POLYAMIDE, POLYAMIDE-ACID OR POLYAMIDE-AMIDE-ACIDS | CIBA-GEIGY CORPORATION (US) | 1976-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570899-B2 | Bright silver based quaternary nanostructures | LGALS3, ANXA3, ATXN2L | DNM1 4621/4885MEN1 4629/4885KMT2A 1613/4885 |
| US-12594700-B2 | Coatings from polyisocyanurate coatings (rim) and their use in injection molding processes | TST, C9, ESD | DNM1 4874/4885MEN1 1073/4885KMT2A 1410/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.